Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gerken

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Surgical Research|March 14, 2023
Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyMiklos Acs, Michael Gerken, Jozef Zustin, et al.
Surgical Endoscopy|March 2, 2021
Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in GermanyVinzenz Völkel, Sabine Schatz, Teresa Draeger, et al.
Chemical Communications (Cambridge, England)|August 7, 2012
SF4·N(C2H5)3: the first conclusively characterized SF4 adduct with an organic baseJames T Goettel, Praveen Chaudhary, Paul Hazendonk, et al.
Chirurgie (Heidelberg, Germany)|August 20, 2022
[Surgical treatment of adenocarcinoma of the esophagogastric junction type II : Comparison between transhiatal extended gastrectomy and thoracoabdominal esophagectomy]Roman Stürzl, Michael Gerken, Christiane Bruns, et al.
Inorganic Chemistry|November 17, 2020
Reactions of Molybdenum and Tungsten Oxide Tetrafluoride with Sulfur(IV) Lewis Bases: Structure and Bonding in [WOF<sub>4</sub>]<sub>4</sub>, MOF<sub>4</sub>(OSO), and [SF<sub>3</sub>][M<sub>2</sub>O<sub>2</sub>F<sub>9</sub>] (M = Mo, W)Douglas Turnbull, Praveen Chaudhary, Dakota Leenstra, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2020
Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancerAndreas Teufel, Michael Gerken, Alois Fürst, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2022
Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and durationKatharina Röhrmoser, Atanas Ignatov, Michael Gerken, et al.
Inorganic Chemistry|October 5, 2021
Lewis Acid Behavior of MoF<sub>5</sub> and MoOF<sub>4</sub>: Syntheses and Characterization of MoF<sub>5</sub>(NCCH<sub>3</sub>), MoF<sub>5</sub>(NC<sub>5</sub>H<sub>5</sub>)<sub></sub>, and MoOF<sub>4</sub>(NC<sub>5</sub>H<sub>5</sub>)<sub></sub> (<i>n</i> = 1, 2)Janelle Bykowski, Douglas Turnbull, Nolan Hahn, et al.
Archives of Gynecology and Obstetrics|January 5, 2019
Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registryTheresa Wimmer, Olaf Ortmann, Michael Gerken, et al.
Anticancer Research|January 30, 2022
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes <i>Versus</i> 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume CentreMiklos Acs, Laszlo Halmy, Sabina Isgandarova, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Surgical Research|March 14, 2023
Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyMiklos Acs, Michael Gerken, Jozef Zustin, et al.
Surgical Endoscopy|March 2, 2021
Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in GermanyVinzenz Völkel, Sabine Schatz, Teresa Draeger, et al.
Chemical Communications (Cambridge, England)|August 7, 2012
SF4·N(C2H5)3: the first conclusively characterized SF4 adduct with an organic baseJames T Goettel, Praveen Chaudhary, Paul Hazendonk, et al.
Chirurgie (Heidelberg, Germany)|August 20, 2022
[Surgical treatment of adenocarcinoma of the esophagogastric junction type II : Comparison between transhiatal extended gastrectomy and thoracoabdominal esophagectomy]Roman Stürzl, Michael Gerken, Christiane Bruns, et al.
Inorganic Chemistry|November 17, 2020
Reactions of Molybdenum and Tungsten Oxide Tetrafluoride with Sulfur(IV) Lewis Bases: Structure and Bonding in [WOF<sub>4</sub>]<sub>4</sub>, MOF<sub>4</sub>(OSO), and [SF<sub>3</sub>][M<sub>2</sub>O<sub>2</sub>F<sub>9</sub>] (M = Mo, W)Douglas Turnbull, Praveen Chaudhary, Dakota Leenstra, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2020
Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancerAndreas Teufel, Michael Gerken, Alois Fürst, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2022
Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and durationKatharina Röhrmoser, Atanas Ignatov, Michael Gerken, et al.
Inorganic Chemistry|October 5, 2021
Lewis Acid Behavior of MoF<sub>5</sub> and MoOF<sub>4</sub>: Syntheses and Characterization of MoF<sub>5</sub>(NCCH<sub>3</sub>), MoF<sub>5</sub>(NC<sub>5</sub>H<sub>5</sub>)<sub></sub>, and MoOF<sub>4</sub>(NC<sub>5</sub>H<sub>5</sub>)<sub></sub> (<i>n</i> = 1, 2)Janelle Bykowski, Douglas Turnbull, Nolan Hahn, et al.
Archives of Gynecology and Obstetrics|January 5, 2019
Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registryTheresa Wimmer, Olaf Ortmann, Michael Gerken, et al.
Anticancer Research|January 30, 2022
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes <i>Versus</i> 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume CentreMiklos Acs, Laszlo Halmy, Sabina Isgandarova, et al.
Pageof 18